Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-004725

Chief Financial Officer sold 2,500 shares at $241.86 ($604,650)

  • Chief Financial Officer acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sandercock Brett · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-10 Exercise or conversion : show line 1 in the form +2,500 $57.76 $144,400 108,854 D
2022-02-10 Sale : show line 2 in the form −2,500 $241.86 $604,650 106,354 D
Open-market sales · 2,500 sh · avg $241.86 · $604,650

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-10 Exercise or conversion : show line 3 in the form ResMed Common Stock Options −2,500 15,000 D
Loading xslF345X03/form4.xml…